Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population

Abstract Background Previous studies demonstrated increases in diagnostic confidence and change in patient management after amyloid-PET. However, studies investigating longitudinal outcomes over an extended period of time are limited. Therefore, we aimed to investigate clinical outcomes up to 9 year...

詳細記述

書誌詳細

主要な著者:	Lyduine E. Collij, Gill Farrar, Marissa Zwan, Elsmarieke van de Giessen, Rik Ossenkoppele, Frederik Barkhof, Annemieke J. M. Rozemuller, Yolande A. L. Pijnenburg, Wiesje M. van der Flier, Femke Bouwman
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-11-01
シリーズ:	Alzheimer’s Research & Therapy
主題:	[18F]flutemetamol amyloid-PET Early-onset dementia Diagnosis Survival Neuropathology
オンライン･アクセス:	https://doi.org/10.1186/s13195-023-01351-1
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!